Farukh Arjmand

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Molecular Docking

Top Venues

Dalton transactions (Cambridge, England : 2003)

Chemical record (New York, N.Y.)

Metallomics : integrated biometal science

This page only lists publications with an associated author ORCID identifier.

Publications

null Rijwan, Farukh Arjmand, Sartaj Tabassum
Repurposing the antihistamine drug bilastine as an anti-cancer metallic drug entity: synthesis and single-crystal X-ray structure analysis of metal-based bilastine and phen [Co(II), Cu(II) and Zn(II)] tailored anticancer chemotherapeutic agents against resistant cancer cells. Dalton transactions (Cambridge, England : 2003) 53 (24) (2024)
null Rijwan, Farukh Arjmand, Sartaj Tabassum
Repurposing the antihistamine drug bilastine as an anti-cancer metallic drug entity: synthesis and single-crystal X-ray structure analysis of metal-based bilastine and phen [Co(II), Cu(II) and Zn(II)] tailored anticancer chemotherapeutic agents against resistant cancer cells. Dalton transactions (Cambridge, England : 2003) 53 (24) (2024)
null Rijwan, Farukh Arjmand, Sartaj Tabassum
Repurposing the antihistamine drug bilastine as an anti-cancer metallic drug entity: synthesis and single-crystal X-ray structure analysis of metal-based bilastine and phen [Co(II), Cu(II) and Zn(II)] tailored anticancer chemotherapeutic agents against resistant cancer cells. Dalton transactions (Cambridge, England : 2003) (2024)
Farukh Arjmand, Huzaifa Yasir Khan, Sartaj Tabassum
Progress of Metal-Based Anticancer Chemotherapeutic Agents in Last two Decades and their Comprehensive Biological (DNA/RNA Binding, Cleavage and Cytotoxicity Activity) Studies. Chemical record (New York, N.Y.) 23 (3) (2023)
Farukh Arjmand, Huzaifa Yasir Khan, Sartaj Tabassum
Progress of Metal-Based Anticancer Chemotherapeutic Agents in Last two Decades and their Comprehensive Biological (DNA/RNA Binding, Cleavage and Cytotoxicity Activity) Studies. Chemical record (New York, N.Y.) 23 (3) (2023)
Farukh Arjmand, Huzaifa Yasir Khan, Sartaj Tabassum
Progress of Metal-Based Anticancer Chemotherapeutic Agents in Last two Decades and their Comprehensive Biological (DNA/RNA Binding, Cleavage and Cytotoxicity Activity) Studies. Chemical record (New York, N.Y.) 23 (3) (2023)
Farukh Arjmand, Huzaifa Yasir Khan, Sartaj Tabassum
Progress of Metal-Based Anticancer Chemotherapeutic Agents in Last Two Decades and their Comprehensive Biological (DNA/RNA Binding, Cleavage and Cytotoxicity Activity) Studies. Chemical record (New York, N.Y.) (2023)
Suffora Akhter, Salman Khursheed, Farukh Arjmand, Sartaj Tabassum
Revelation of potential bioactive water-soluble Boc-L-valine and imidazole appended metal complexes {M = Co(II), Cu(II) & Zn(II)}: synthesis, characterization, ct-DNA binding, pBR322 cleavage, SOD mimetic, and cytotoxicity studies. Dalton transactions (Cambridge, England : 2003) (2023)
Suffora Akhter, Farukh Arjmand, Claudio Pettinari, Sartaj Tabassum
Ru(II)( ƞ 6 - p -cymene) Conjugates Loaded onto Graphene Oxide: An Effective pH-Responsive Anticancer Drug Delivery System. Molecules (Basel, Switzerland) 27 (21) (2022)
Salman Khursheed, Hifzur R Siddique, Sartaj Tabassum, Farukh Arjmand
Water soluble transition metal [Ni(II), Cu(II) and Zn(II)] complexes of N -phthaloylglycinate bis(1,2-diaminocyclohexane). DNA binding, pBR322 cleavage and cytotoxicity. Dalton transactions (Cambridge, England : 2003) 51 (31) (2022)
Siffeen Zehra, Ilenia Cirilli, Sonia Silvestri, Santiago Gómez-Ruiz, Sartaj Tabassum, Farukh Arjmand
Structure elucidation, in vitro binding studies and ROS-dependent anti-cancer activity of Cu(II) and Zn(II) phthaloylglycinate(phen) complexes against MDA-MB-231 cells. Metallomics : integrated biometal science 13 (11) (2022)
Sabiha Parveen, James Allan Cowan, Zhen Yu, Farukh Arjmand
Enantiomeric copper based anticancer agents promoting sequence-selective cleavage of G-quadruplex telomeric DNA and non-random cleavage of plasmid DNA. Metallomics : integrated biometal science 12 (6) (2021)
Farukh Arjmand, Surbhi Sharma, Sabiha Parveen, Loic Toupet, Zhen Yu, James Allan Cowan
Copper(ii) l/d-valine-(1,10-phen) complexes target human telomeric G-quadruplex motifs and promote site-specific DNA cleavage and cellular cytotoxicity. Dalton transactions (Cambridge, England : 2003) 49 (28) (2021)
Huzaifa Yasir Khan, Sartaj Tabassum, Farukh Arjmand
Evaluation of cytotoxic potential of structurally well-characterized RNA targeted ionic non-steroidal anti-inflammatory (NSAID) Cu(ii) & Zn(ii) DACH-mefenamato drug conjugates against human cancer cell lines. RSC advances 10 (1) (2019)
Farukh Arjmand, Zeenat Afsan, Thierry Roisnel
Design, synthesis and characterization of novel chromone based-copper(ii) antitumor agents with N , N -donor ligands: comparative DNA/RNA binding profile and cytotoxicity. RSC advances 8 (65) (2018)